Publications by authors named "R Dienstmann"

Claim this Profile
E
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.
E Elez, S Siena, A Sartore-Bianchi, J Ros, F Ciardello, R Dienstmann

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.
Elena Garralda, Charles Abbott, Alma Calahorro, Oriol Mirallas, Jason Pugh, Rodrigo Dienstmann

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors.
R Dienstmann, A Vivancos, P Nuciforo, S Aguilar, F Ruiz-Pace

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6.
Leandro Jonata Carvalho Oliveira, Max Senna Mano, Carlos Barrios, Rodrigo Dienstmann

Breast Cancer Res Treat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts.
Andreu Òdena, Laia Monserrat, Fara Brasó-Maristany, Eduardo García-Galea, Eloi Casals, Rodrigo Dienstmann

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis